Disparities in risk stratification guidance for patients taking immunosuppressive drugs during the COVID-19 pandemic – points to ponder.

Thumbnail
Author
Sapkota, Hem Raj
Date
2022-06-17
Type
Letter/Correspondence
Keyword
COVID-19; Risk; Immunosuppressive drugs; Autoimmune inflammatory diseases; Rheumatology; Dermatology; Gastroenterology
Journal Title
Journal of the Royal College of Physicians of Edinburgh
Volume
52
Issue
2
Begin page
185
End page
187
Metadata
Show full item record
URI
https://rwt.dspace-express.com/handle/20.500.12687/1274
DOI
https://doi.org/10.1177/14782715221103739
Abstract
No abstract available.
Citation
Nune A, Ish P, Iyengar KP, Mago A, Khan N, Raj Sapkota H. Disparities in risk stratification guidance for patients taking immunosuppressive drugs during the COVID-19 pandemic - points to ponder. J R Coll Physicians Edinb. 2022 Jun;52(2):185-187. doi: 10.1177/14782715221103739. Epub 2022 Jun 17. PMID: 36147005.
Publisher Link
https://journals.sagepub.com/doi/epub/10.1177/14782715221103739
Rights
Attribution 3.0 United States
Collections

The following license files are associated with this item:

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States